Nimesulide - A multifactorial approach to inflammation and pain: Scientific and clinical consensus

Current Medical Research and Opinion

Volumn 22, Issue 6, 2006, Pages 1161-1170

  Rainsford, K D ^a  

^a SHEFFIELD HALLAM UNIVERSITY   (United Kingdom)

Author keywords

Analgesic; Anti inflammatory; Nimesulide; NSAID; Side effects; Sulphonanilide

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; ANTIINFLAMMATORY AGENT; CARBOXYLIC ACID; CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; DIFLUNISAL; ETODOLAC; ETORICOXIB; FURANONE DERIVATIVE; HISTAMINE; IBUPROFEN; INDOMETACIN; KETOPROFEN; LUMIRACOXIB; MECLOFENAMIC ACID; MEFENAMIC ACID; MELOXICAM; NAPROXEN; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; OXICAM DERIVATIVE; PARECOXIB; PIROXICAM; PYRAZOLE; ROFECOXIB;

ANALGESIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIPYRETIC ACTIVITY; APOPTOSIS; AREA UNDER THE CURVE; BLEEDING; BRONCHOSPASM; CARDIOVASCULAR MALFORMATION; CHEMICAL STRUCTURE; CHEMOTAXIS; CLINICAL TRIAL; CONSENSUS; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG HALF LIFE; DRUG MECHANISM; DRUG SAFETY; DRUG USE; DYSMENORRHEA; EX VIVO STUDY; HEPATOBILIARY DISEASE; HUMAN; HYPERSENSITIVITY; IMMUNOPATHOLOGY; IN VIVO STUDY; INCIDENCE; INFLAMMATION; KIDNEY DISEASE; KIDNEY FUNCTION; LIVER DISEASE; LIVER TOXICITY; MENTAL DISEASE; NEUROLOGIC DISEASE; OSTEOARTHRITIS; PAIN; REVIEW; RHINITIS; SKIN DISEASE; SPRAIN; TENDINITIS; TREATMENT OUTCOME; ULCER; URINARY DYSFUNCTION; URTICARIA;

ANALGESICS, NON-NARCOTIC; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYCLOOXYGENASE INHIBITORS; HUMANS; INFLAMMATION; PAIN; SULFONAMIDES;

EID: 33745714062     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079906X104849     Document Type: Review

References (32)

1. Rainsford KD, editor. Nimesulide. Actions and uses. Basel: Birkhäuser, 2005
2. European Medicines Evaluation Agency, Committee for Proprietary Medicinal Products. Nimesulide containing medicinal products. CPMP/1724/04. Available from http://www.emea.eu.int/pdfs/human/referral/nimesulide/172404en.pdf [Last accessed Jan 2006]
3. Rainsford KD. The discovery, development and novel actions of nimesulide. In: Rainsford KD, editor. Nimesulide. Actions and uses. Basel: Birkhäuser, 2005. pp.1-61
4. Swingle KF, Bell RL, Moore GGI. Anti-inflammatory activity of antioxidants. In: Anti-inflammatory and anti-rheumatic drugs. Volume III: anti-rheumatic drugs, experimental agents, and clinical aspects of drug use. Boca Raton (Fl): CRC Press, 1985. pp. 105-26
5. Bernareggi A. Clinical pharmacokinetics of nimesulide. Clin Pharmacokinet 1998;35:247-74
6. Bernareggi A, Rainsford KD. Pharmacokinetics of nimesulide. In: Rainsford KD, editor. Nimesulide. Actions and uses. Basel: Birkhäuser, 2005. pp.63-120
7. Maroni A, Gazzaniga A, Rainsford KD. Pharmacokinetics of nimesulide. In: Rainsford KD, editor. Nimesulide. Actions and uses. Basel: Birkhäuser, 2005. pp.121-32
8. Bennett A. Nimesulide: a well-established cyclo-oxygenase-2 inhibitor with many other pharmacological properties relevant to inflammatory disease. In: Vane JR, Botting RM, editors. Therapeutic roles of selective COX-2 inhibitors. London: William Harvey Press, 2001. pp.524-40
9. Bennett A, Villa G. Nimesulide: an NSAID that preferentially inhibits COX-2, and has various unique pharmacological activities. Exp Opin Pharmacother 2000;1:277-86
10. Warner TD, Giuliano F, Vojnovic I, et al. Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis. Proc Natl Acad Sci U S A 1999;96:7563-8. Erratum p.9666
11. Rainsford KD, Bevilacqua M, Dallegri, et al. Pharmacological properties of nimesulide. In: Rainsford KD, editor. Nimesulide. Actions and uses. Basel: Birkhäuser, 2005. pp.133-244
12. Bianchi M, Ehrlich GE, Facchinetti F, et al. Clinical applications of nimesulide in pain, arthritic conditions and fever. In: Rainsford KD, editor. Nimesulide. Actions and uses. Basel: Birkhäuser, 2005. pp.245-313
13. Bianchi M, Broggini M. Anti-hyperalgesic effect of nimesulide: studies in rats and humans. Int J Clin Pract 2002;128:11-9
14. Sandrini G, Proietti Cecchini A, Alfonsi E, et al. Effectiveness of nimesulide in pain. A neurophysiological study in humans. Drugs Today 2001;37(B):21-9
15. Jenoure P, Gorschewsky O, Ryf C, et al. Randomised double-blind study of nimesulide versus diclofenac in adults with acute sport injuries. J Clin Res 1998;1:343-56
16. Wober W. Comparative efficacy and safety of nimesulide and diclofenac in patients with acute shoulder, and a meta-analysis of controlled studies with nimesulide. Rheumatology (Oxford) 1999;38(Suppl 1):33-8
17. Pohjolainen T, Jekunen A, Lotta A, et al. Treatment of acute low back pain (LBP) with the COX-2 selective NSAR nimesulide: results of a randomised, double-blind, comparative trial vs. ibuprofen. Spine 2000;25:1579-85
18. Ferrari Parabita G, Zanetti U, Scalvini F, et al. A controlled clinical study of the efficacy and tolerability of nimesulide vs. naproxen in maxillo-facial surgery. Drugs 1993;46(Suppl 1):171-3
19. American College of Rheumatology. Subcommittee on osteoarthritis guidelines: recommendations for the medical management of osteoarthritis of the hip and knee. Arthritis Rheum 2000;43:1905-15
20. Barracchini A, Franceschini N, Amicosante G, et al. Can non-steroidal anti-inflammatory drugs act as metalloproteinase modulators? An in-vitro study of inhibition of collagenase activity. J Pharm Pharmacol 1998;50:1417-23
21. Bevilacqua M, Devogelaer J-P, Righini V, et al. Effect of nimesulide on the serum levels of hyaluronan and stromelysin-1 in patients with osteoarthritis: a pilot study. Int J Clin Pract 2004;144(Suppl):13-9
22. Huskisson EC, Macciocchi A, Rahlfs VW, et al. Nimesulide versus diclofenac in the treatment of osteoarthritis of the hip or knee: an active controlled equivalent study. Curr Ther Res 1999;60:253-65
23. Kriegel W, Korff KJ, Ehrlich JC, et al. Double-blind study comparing the long-term efficacy of the COX-2 inhibitor nimesulide and naproxen in patients with osteoarthritis. Int J Clin Pract 2001;55:510-4
24. Bianchi M, Broggini M. A randomised, double-blind, clinical trial comparing the efficacy of nimesulide, celecoxib and rofecoxib in osteoarthritis of the knee. Drugs 2003;63(Suppl 1):37-46
25. Pulkkinen MO. Is there a rationale for the use of nimesulide in the treatment of dysmenorrhea? Drugs Today 2001;37(Suppl B):31-8
26. Facchinetti F, Piccinini F, Sgarbi L, et al. Nimesulide in the treatment of primary dysmenorrhea: a double-blind study versus diclofenac. Drugs Today 2001;37(Suppl B):39-45
27. Bjarnason I, Bissoli F, Conforti A, et al. Adverse reactions and their mechanisms from nimesulide. In: Rainsford KD, editor. Nimesulide. Actions and uses. Basel: Birkhäuser, 2005. pp.315-415
28. Shah AA, Thjodleifsson B, Murray FE, et al. Selective inhibition of COX-2 in humans is associated with less gastro-intestinal injury: a comparison of nimesulide and naproxen. Gut 2001;48:339-46
29. Conforti A, Leone R, Moretti U, et al. Adverse drug reactions related to the use of NSAIDs with a focus on nimesulide. Drug Saf 2001;24:1081-90
30. Laporte JR, Ibanez I, Vidal X, et al. Upper gastro-intestinal bleeding associated with the use of NSAIDs: newer vs. older agents. Drug Saf 2004;27:411-20
31. Boelsterli UA. Nimesulide and hepatic adverse effects: roles of reactive metabolites and host factors. Int J Clin Pract Suppl 2002;128:30-6
32. Traversa G, Bianchi C, Da Cas R, et al. Cohort study of hepatotoxicity associated with nimesulide and other non-steroidal anti-inflammatory drugs. BMJ 2003;327:18-22